TRENTON, N.J. (AP) — For Alzheimer's patients desperate for an effective treatment, several new studies starting up offer hope.
After dozens of promising experimental drugs failed, scientists think they're now on the right track, targeting the mechanisms to arrest the epidemic, mind-robbing disease.
Dr. William H. Thies, the Alzheimer's Association's top scientist, says if the new studies succeed, a medicine that slows or even stops progression of Alzheimer's might be ready in three to five years. That's only if tens of millions of dollars more are found for research and more patients join clinical studies.
Drugmakers including Merck & Co., Eli Lilly and Co. and the Roche Group are working on drugs that use different mechanisms to limit accumulation in the brain of the amyloid plaques considered the most likely cause of Alzheimer's.
Concealed Carrier Shoots Armed Robber In Detroit... Again. Still. - Bearing Arms - Detroit, Guns Saving Lives, Michigan
The Koran’s Contents—Not Carbon Dating—Cast More Doubt on Islam’s Origins | Human Events
This Missouri college student is the sole vote on whether a sales tax will be increased
'Gut wrenching': Deputy Goforth's son wears superhero shirt to funeral he planned to wear with his dad
Humberto Fontova - Migrant to Mexico Defends Trump, Denounces Ramos
Peter Schiff - Meet QT; QE's Evil Twin
An Unserious Candidate for an Unserious Country | RedState